Selegiline and mortality in Parkinson's disease

被引:41
作者
Olanow, CW
Fahn, S
Langston, JW
Godbold, J
机构
[1] COLUMBIA UNIV, DEPT NEUROL, NEW YORK, NY 10027 USA
[2] MT SINAI SCH MED, DEPT COMMUNITY MED, NEW YORK, NY USA
[3] PARKINSON INST, SANTA CLARA, CA USA
关键词
D O I
10.1002/ana.410400605
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:841 / 845
页数:5
相关论文
共 37 条
[1]  
Ahlskog JE, 1996, MAYO CLIN PROC, V71, P659
[2]  
ANSARI KS, 1993, J NEUROSCI, V13, P4042
[3]   SURVIVAL AND CAUSE OF DEATH IN A COHORT OF PATIENTS WITH PARKINSONISM - POSSIBLE CLUES TO ETIOLOGY [J].
BENSHLOMO, Y ;
MARMOT, MG .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (03) :293-299
[4]   INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].
BIRKMAYER, W ;
KNOLL, J ;
RIEDERER, P ;
YOUDIM, MBH ;
HARS, V ;
MARTON, J .
JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127
[5]   POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].
BIRKMAYER, W ;
RIEDERER, P ;
YOUDIM, MBH ;
LINAUER, W .
JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326
[6]   In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism [J].
Brannan, T ;
Prikhojan, A ;
MartinezTica, J ;
Yahr, MD .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1995, 10 (2-3) :79-89
[7]   Selegiline in Parkinson's disease - No neuroprotective effect: Increased mortality [J].
Calne, DB .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7020) :1583-1584
[8]  
CANNER PL, 1981, CONTROL CLIN TRIALS, V1, P363
[9]   PARGYLINE AND DEPRENYL PREVENT THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MONKEYS [J].
COHEN, G ;
PASIK, P ;
COHEN, B ;
LEIST, A ;
MYTILINEOU, C ;
YAHR, MD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (01) :209-210
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187